Open access
Open access
Powered by Google Translator Translator

Pediatrics (all articles)

Perspective | The other long Covid: the pandemic took young people’s present. What will it do to their future?

3 Mar, 2023 | 14:05h | UTC

The other long Covid: The pandemic took young people’s present. What will it do to their future? – Vox

 


RCT | Reducing social media use improves appearance and weight esteem in youth with emotional distress

3 Mar, 2023 | 14:04h | UTC

Summary: The article discusses a randomized controlled trial conducted on 220 participants aged 17-25 to examine the effects of reducing smartphone social media use (SMU) on appearance and weight esteem in youth with emotional distress. The participants were divided into an intervention group (limited to 1 hr/day SMU) and a control group (unrestricted SMU). The study found that reducing SMU improved appearance and weight esteem in the intervention group, while the control group showed no significant change. The authors concluded that reducing SMU may be a feasible and effective method of improving body image in a vulnerable youth population and should be evaluated as a potential component in treating body image-related disturbances. It is worth noting, however, that the impossibility of blinding participants and the subjective nature of the endpoints make it difficult to draw definitive conclusions on the subject.

Article: Reducing Social Media Use Improves Appearance and Weight Esteem in Youth With Emotional Distress – American Psychological Association

News Release: Reducing social media use significantly improves body image in teens, young adults – American Psychological Association

Commentary: How to help young people limit screen time — and feel better about how they look – NPR

 


Maternal diabetes and overweight as risk factors for congenital heart defects in offspring – A nationwide register study from Finland

3 Mar, 2023 | 13:51h | UTC

Summary: The study aimed to determine the association between maternal diabetes and overweight/obesity and the risk of congenital heart defects (CHDs) in offspring. The study analyzed data from all children born in Finland between 2006 and 2016 and their mothers. Maternal type 1 diabetes (T1DM) was found to be associated with a significantly increased risk for any CHD, with an odds ratio of 3.71, whereas maternal overweight and obesity were associated with only a slightly increased risk for complex defects and left ventricular outflow tract obstruction. Maternal diabetes was responsible for 3.0% of offspring’s CHD, while maternal overweight and obesity were responsible for 0.7%, indicating weaker associations between maternal overweight and obesity and CHD in the offspring than previously reported.

[Preprint] Maternal diabetes and overweight as risk factors for congenital heart defects in offspring – A nationwide register study from Finland – medRxiv

 

Commentary from the author on Twitter

 


SR | Interventions for preventing and treating kidney disease in IgA vasculitis

3 Mar, 2023 | 13:47h | UTC

Interventions for preventing and treating kidney disease in IgA vasculitis – Cochrane Library

Summary: Interventions for preventing and treating kidney disease in IgA vasculitis (Henoch-Schönlein Purpura) – Cochrane Library

 


Youth-onset type 2 diabetes: the epidemiology of an awakening epidemic

2 Mar, 2023 | 13:01h | UTC

Youth-Onset Type 2 Diabetes: The Epidemiology of an Awakening Epidemic – Diabetes Care

 


M-A | Thromboprophylaxis in patients with Fontan circulation

2 Mar, 2023 | 12:57h | UTC

Thromboprophylaxis in Patients With Fontan Circulation – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Commentary: Thromboprophylaxis in Patients With Fontan Circulation – American College of Cardiology

 

Commentary from the author on Twitter (thread – click for more)

 


RCT | Impact of supplementation with milk–cereal mix during 6–12 months of age on growth at 12 months in Delhi, India

2 Mar, 2023 | 12:50h | UTC

Impact of supplementation with milk–cereal mix during 6–12 months of age on growth at 12 months: a 3-arm randomized controlled trial in Delhi, India – The American Journal of Clinical Nutrition

Commentary: High-protein supplementation improves linear growth in infants – 2 Minute Medicine

 


Brief Review | Acute rheumatic fever: recent advances

2 Mar, 2023 | 12:41h | UTC

Acute Rheumatic Fever: Recent Advances – The Pediatric Infectious Disease Journal (free for a limited period)

 


Pediatric clinical practice adapted guidelines for management of nephrotic syndrome

1 Mar, 2023 | 14:01h | UTC

Part 1: Steroid sensitive nephrotic syndrome

Part 2: Steroid-resistant nephrotic syndrome

Related: IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome – Pediatric Nephrology

 


IPNA Recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome

1 Mar, 2023 | 13:59h | UTC

IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome – Pediatric Nephrology

Related:

Egyptian evidence -based pediatric clinical practice adapted guidelines for management of steroid sensitive nephrotic syndrome

Egyptian pediatric clinical practice adapted guidelines: evidence-based steroid-resistant nephrotic syndrome

 


WHO Report | A woman dies every two minutes due to pregnancy or childbirth

28 Feb, 2023 | 14:04h | UTC

Summary: This new report by United Nations agencies shows that a woman dies every two minutes due to pregnancy or childbirth. The report covers maternal deaths from 2000 to 2020 and reveals that maternal deaths either increased or stagnated in nearly all regions of the world, with some regions experiencing major setbacks. The poorest parts of the world and countries affected by conflict continue to have the highest rates of maternal deaths. Severe bleeding, high blood pressure, pregnancy-related infections, complications from unsafe abortion, and underlying conditions aggravated by pregnancy are the leading causes of maternal deaths, which are largely preventable and treatable with access to high-quality healthcare. The COVID-19 pandemic may have further held back progress on maternal health. The report calls for urgent action to ensure every woman and girl has access to critical health services before, during, and after childbirth, so they can fully exercise their reproductive rights.

News Release: A woman dies every two minutes due to pregnancy or childbirth: UN agencies – World Health Organization

Report: Trends in maternal mortality 2000 to 2020: estimates by WHO, UNICEF, UNFPA, World Bank Group and UNDESA/Population Division – World Health Organization

Commentaries:

Ambitious goal to slash maternal deaths in jeopardy – Nature

U.N.: Progress on reducing global maternal mortality has stalled since 2015 – STAT

Eight Hundred Women Die Every Day During Pregnancy or Childbirth – Health Policy Watch

 


Brief Review | Congenital infections: priorities and possibilities for resource-limited settings

1 Mar, 2023 | 13:32h | UTC

Congenital Infections: Priorities and Possibilities for Resource-limited Settings – The Pediatric Infectious Disease Journal (free for a limited period)

 


Perspective | Gender dysphoria in young people is rising — and so is professional disagreement

28 Feb, 2023 | 13:55h | UTC

Gender dysphoria in young people is rising—and so is professional disagreement – The BMJ

News Release: Gender dysphoria is rising—and so is professional disagreement – BMJ Newsroom

 

Commentary on Twitter

 


RCT | 2-y outcomes confirm the harms caused by high prophylactic platelet transfusion thresholds in preterm infants

28 Feb, 2023 | 13:53h | UTC

Summary: The study investigated the long-term outcomes of preterm infants who participated in a randomized trial of platelet transfusions at different threshold levels. Infants with platelet counts below 50×109/L were enrolled and randomized to either a higher threshold of 50×109/L or a lower threshold of 25×109/L. The study found that infants randomized to the higher threshold had a higher rate of death or significant neurodevelopmental impairment at a corrected age of 2 years compared to the lower threshold group. The study further supports evidence of harm caused by high prophylactic platelet transfusion thresholds in preterm infants. The mechanisms by which platelet transfusions could mediate harmful effects remain unknown, but the study identified increased rates of intraventricular hemorrhage and bronchopulmonary dysplasia in the higher threshold group, which may contribute to the adverse outcomes observed.

Article: Two-year outcomes following a randomised platelet transfusion trial in preterm infants – ADC Fetal & Neonatal

Original Study: Randomized Trial: Platelet-Transfusion Thresholds in Neonates

 

Commentary from the author on Twitter (thread – click for more)

 


AAP Policy Statement | Crowding in the emergency department: challenges and recommendations for the care of children

28 Feb, 2023 | 13:50h | UTC

Guideline: Crowding in the Emergency Department: Challenges and Recommendations for the Care of Children – Pediatrics

Technical Report: Crowding in the Emergency Department: Challenges and Best Practices for the Care of Children – Pediatrics

News Release: Crowding in the ED: AAP guidance offers solutions to complex problem – American Academy of Pediatrics

 


SR | Insufficient evidence to recommend Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia

28 Feb, 2023 | 13:39h | UTC

Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia – Cochrane Library

 


The adult and pediatric palliative care: differences and shared issues

28 Feb, 2023 | 13:30h | UTC

The adult and pediatric palliative care: differences and shared issues – Journal of Anesthesia, Analgesia and Critical Care

 


Cross-sectional study | Risk factors for hearing loss at birth in newborns with congenital CMV infection

28 Feb, 2023 | 13:20h | UTC

Risk Factors for Hearing Loss at Birth in Newborns With Congenital Cytomegalovirus Infection – JAMA Pediatrics (link to abstract – $ for full-text)

Commentary: Factors ID’d for Hearing Loss in Newborns With Congenital Cytomegalovirus – HealthDay

 

Commentaries on Twitter

 


RCT | Tight glycemic control did not preserve pancreatic beta cell function in newly diagnosed pediatric type 1 diabetes

27 Feb, 2023 | 13:16h | UTC

Summary: The study aimed to determine if intensive diabetes management with an automated insulin delivery system could help preserve pancreatic beta cell function in youth with newly diagnosed type 1 diabetes. The randomized clinical trial included 113 youths aged 7 to 17 years and found that although the mean time in the target range of 70 to 180 mg/dL was 78% in the intensive management group vs. 64% in the standard care group, intensive diabetes management did not affect the decline in pancreatic C-peptide secretion at 52 weeks. The study concluded that near normalization of glucose levels instituted immediately after diagnosis of type 1 diabetes did not preserve pancreatic beta cell function in youth.

Article: Effect of Tight Glycemic Control on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: Preserving Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes – JAMA (free for a limited period)

 

Commentary on Twitter

 


RCT | Verapamil partially preserved pancreatic beta cell function in newly diagnosed pediatric type 1 diabetes

27 Feb, 2023 | 13:14h | UTC

Summary: The study aimed to determine whether verapamil could preserve pancreatic beta cell function in children and adolescents with newly diagnosed type 1 diabetes. The randomized clinical trial involved 88 participants who were given either verapamil or placebo once daily for 52 weeks. The study found that C-peptide levels were 30% higher in the verapamil group compared to the placebo group at 52 weeks, and the percentage of participants with a 52-week peak C-peptide level of 0.2 pmol/mL or greater was 95% in the verapamil group compared to 71% in the placebo group. The study also found that verapamil was well tolerated with few adverse events. The results suggest that verapamil may partially preserve stimulated C-peptide secretion in children and adolescents with newly diagnosed type 1 diabetes. However, further studies with patient-relevant outcomes are needed to determine the long-term effectiveness and the optimal length of therapy.

Article: Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: Preserving Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes – JAMA (free for a limited period)

News Release: Verapamil shows beneficial effect on the pancreas in children with newly-diagnosed type 1 diabetes – University of Minnesota

 

Commentary on Twitter

 


Review | Diagnostic workup of childhood interstitial lung disease

27 Feb, 2023 | 12:50h | UTC

Diagnostic workup of childhood interstitial lung disease – European Respiratory Review

 

Commentary on Twitter

 


Review | Management of gastrointestinal foreign bodies with brief review of the guidelines

24 Feb, 2023 | 13:36h | UTC

Management of Gastrointestinal Foreign Bodies with Brief Review of the Guidelines – Pediatric Gastroenterology, Hepatology & Nutrition

 


SR | The impact of Antimicrobial Stewardship Programs in pediatric emergency departments and primary care

24 Feb, 2023 | 13:20h | UTC

The impact of Antimicrobial Stewardship Programmes in paediatric emergency departments and primary care: a systematic review – Therapeutic Advances in Infectious Disease

 


M-A | Low-dose insulin infusion is safe and effective in treating diabetic ketoacidosis in children

23 Feb, 2023 | 13:40h | UTC

Summary: The article discusses a systematic review and meta-analysis of randomized controlled trials comparing low-dose insulin at 0.05 units/kg/hr to standard dose at 0.1 units/kg/hr for children with diabetic ketoacidosis (DKA). The study found that low-dose insulin infusion is probably as efficacious and safer than standard-dose insulin in treating DKA in children, as it has no effect on the time to resolution of hyperglycemia or acidosis and probably reduces the risk of developing hypokalemia and hypoglycemia. However, the results are limited by imprecision and generalizability to other settings since all studies were performed in a single country. Therefore, further studies are required to identify the optimal insulin dose for children with DKA in terms of safety and effectiveness.

Article: Insulin Infusion Dosing in Pediatric Diabetic Ketoacidosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials – Critical Care Explorations

 


M-A | Disordered eating affects 1 in 5 children and adolescents

23 Feb, 2023 | 13:33h | UTC

Summary: The text reports the findings of a systematic review and meta-analysis that included 32 studies on the global proportion of disordered eating in children and adolescents aged 6 to 18 years, assessed with the SCOFF questionnaire, a widely used screening measure for eating disorders. The review found that approximately 22% of children and adolescents showed disordered eating, which was higher among girls, older adolescents, and those with higher body mass index. The high figures are concerning from a public health perspective and highlight the need for prevention strategies to address disordered eating. The study has limitations, including the cross-sectional nature of most of the included studies and the use of self-report questionnaires to assess disordered eating, which may be subject to bias.

Article: Global Proportion of Disordered Eating in Children and Adolescents: A Systematic Review and Meta-analysis – JAMA Pediatrics (free for a limited period)

Commentary: What is disordered eating? And why do 20% of the world’s kids show signs of it? Experts explain – CNN

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.